Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
Sobha Sivaprasad, Nachiketa Acharya, Phil HykinMoorfields Eye Hospital, London, UKAbstract: The pathogenesis of age-related macular degeneration (AMD) is unclear, but it can take either a neovascular/exudative/wet form, characterized by choroidal neovascularization (CNV), or a dry form. No treatment...
Guardado en:
Autores principales: | Sobha Sivaprasad, Nachiketa Acharya, Phil Hykin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5387f5b853cd417881facd7c3d727cf5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
por: Sobha Sivaprasad
Publicado: (2008) -
Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany
por: Nikolaus Feucht, et al.
Publicado: (2008) -
Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases
por: Roopa Vemala, et al.
Publicado: (2010) -
Clinical experience with pegaptanib sodium
por: Chiara Rosina, et al.
Publicado: (2008) -
An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema
por: Sivaprasad S, et al.
Publicado: (2014)